The purpose of this report is to discuss the different mechanisms of reperfusion of pulmonary
arteriovenous malformations (PAVMs) after embolization. Transcatheter embolotherapy is …

Background Hereditary hemorrhagic telangiectasia (HHT) is a dominantly inherited disease
with a high prevalence of pulmonary arteriovenous malformations (PAVMs). The first …

Pulmonary arteriovenous malformations (PAVMs) are rare, with an estimated incidence of 2
to 3 cases per 100,000, with most PAVMs (50%-80%) occurring in patients with hereditary …

Purpose: To retrospectively evaluate frequency of systemic arterial collateral supply to
treated pulmonary arteriovenous malformations (PAVMs) in long-term follow-up with multi …

PRINCIPLES: To assess the efficiency and complication rates of vaso-occlusion of
pulmonary arteriovenous malformations (PAVMs) in Rendu-Osler-Weber disease …

OBJECTIVE: To describe outcomes of transcatheter embolotherapy (TCE) in children with
pulmonary arteriovenous malformations (PAVMs). STUDY DESIGN: Chart and imaging …

AIM To report our preliminary experience using a Micro Vascular Plug (MVP) deployed
through a 2.8 Fr micro-catheter for the treatment of pulmonary arteriovenous malformations …

We have treated 21 patients (13 female, 8 male) with pulmonary arteriovenous
malformations (PAVMs). Mean age at diagnosis was 37.5 years (range, 15 to 72 years) …

Objective To evaluate the clinical and radiological outcomes of transcatheter embolotherapy
for treating sporadic pulmonary arteriovenous malformations (PAVMs) that were not …

Pulmonary arteriovenous malformation is a rare anomaly that presents in several different
ways. It can present as an isolated finding, or more often in the context of hereditary …